Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Merchants Bancorp Pref D | MBINM | Mar 17, 2025 | 25.61 | -0.16 |
Merck & Co | MRK | Mar 17, 2025 | 94.79 | +0.23 |
Mercurity Fintech | MFH | Mar 17, 2025 | 6.04 | +16.60 |
Mercury General | MCY | Mar 17, 2025 | 57.22 | -0.05 |
Mercury Systems | MRCY | Mar 17, 2025 | 46.44 | -0.17 |
Mereo BioPharma ADR | MREO | Mar 17, 2025 | 2.63 | +0.38 |
Meridian | MRBK | Mar 17, 2025 | 13.91 | +0.07 |
MeridianLink | MLNK | Mar 17, 2025 | 19.32 | +0.68 |
Merit Medical Systems | MMSI | Mar 17, 2025 | 100.69 | +1.77 |
Meritage Homes | MTH | Mar 17, 2025 | 70.46 | +0.06 |
Merrill Lynch & Co. | IPB | Mar 17, 2025 | 26.10 | +0.21 |
Mersana Therapeutics | MRSN | Mar 17, 2025 | 0.48 | +3.03 |
Merus N.V | MRUS | Mar 17, 2025 | 47.22 | +0.25 |
Mesa Air Group | MESA | Mar 17, 2025 | 0.99 | +3.12 |
Mesa Laboratories | MLAB | Mar 17, 2025 | 128.67 | +1.97 |
Mesa Royalty Trust | MTR | Mar 17, 2025 | 6.30 | +0.04 |
Mesabi Royalty Trust | MSB | Mar 17, 2025 | 26.65 | -0.60 |
Mesoblast ADR | MESO | Mar 17, 2025 | 13.19 | -2.66 |
Meta Platforms A | META | Mar 17, 2025 | 604.90 | -0.44 |
Metagenomi | MGX | Mar 17, 2025 | 1.88 | -3.09 |
Metal Sky Star Acquisition | MSSA | Mar 17, 2025 | 12.00 | 0.00 |
Metalla Royalty & Streaming | MTA | Mar 17, 2025 | 3.06 | -0.65 |
Metallus | MTUS | Mar 17, 2025 | 13.86 | -1.35 |
MetaVia | MTVA | Mar 17, 2025 | 1.59 | +7.44 |
Methalpa Technology Holding | MATH | Mar 17, 2025 | 1.99 | +5.85 |
Methanex | MEOH | Mar 17, 2025 | 37.82 | +0.27 |
Methode Electronics | MEI | Mar 17, 2025 | 6.56 | +1.39 |
MetLife | MET | Mar 17, 2025 | 82.16 | +2.18 |
Metlife Pref A | MET-A | Mar 17, 2025 | 24.70 | +0.20 |
Metlife Pref E | MET-E | Mar 17, 2025 | 24.11 | +0.79 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.